Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | IDH1 | O75874 | 2/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.38 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | PDE2A | O00408 | 1/20 | 0.37 |
| ▸ | CISD2 | Q8N5K1 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5151216 | 0.92 | RXFP1 (0.38) | TRPV1SMN1; SMN2RXFP1CISD2 | |
| SCHEMBL5154485 | 0.87 | SMN1; SMN2 (0.43) | LMNAMAPK1SMN1; SMN2RXFP1NPC1 | |
| SCHEMBL7665668 | 0.85 | KCNQ3 (0.46) | TRPV1SMN1; SMN2RXFP1EPHX2KCNQ3 | |
| SCHEMBL29803307 | 0.79 | RXFP1 (0.55) | MEN1LMNAKMT2ASMN1; SMN2RXFP1 | |
| SCHEMBL7667607 | 0.79 | RXFP1 (0.55) | MEN1LMNAKMT2ASMN1; SMN2RXFP1 | |
| SCHEMBL5149049 | 0.78 | RXFP1 (0.36) | SMN1; SMN2RXFP1PDE2ACISD2 | |
| SCHEMBL6243514 | 0.77 | RXFP1 (0.41) | MEN1LMNAMAPK1KMT2ASMN1; SMN2 | |
| SCHEMBL29803357 | 0.76 | SMN1; SMN2 (0.47) | MEN1LMNAKMT2ASMN1; SMN2RXFP1 | |
| SCHEMBL18703070 | 0.76 | SMN1; SMN2 (0.47) | MEN1LMNAKMT2ASMN1; SMN2RXFP1 | |
| SCHEMBL7794191 | 0.75 | CYP17A1 (0.49) | TRPV1SMN1; SMN2RXFP1EPHX2IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1671941-A1 | SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Industries, Ltd. (JP) | 2006-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043011-A1 | Substituted benzanilide compound and noxious organism controlling agent | L3MBTL1, L3MBTL3, L3MBTL4 | TRPV1 31/4885MEN1 4633/4885LMNA 1667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.